Skip to main content

Association of anemia with sensorineural hearing loss: a systematic review and meta-analysis



Evidence shows that anemic individuals are at a higher risk of hearing loss. However, there is no systematic review and meta-analysis study. Thus, we aimed to meta-analyze the existing evidence on the association of iron deficiency anemia (IDA) with sensorineural hearing loss (SNHL). We searched PubMed, MEDLINE, Embase, Scopus, and Google Scholar from inception through October 30, 2017, for studies done on the association of the IDA with SNHL. Pooled odds ratio (OR) was calculated by random effect meta-analysis method. Heterogeneity was assessed by I2 metrics.


Four studies, covering a total of 344,080 adults and children, were included. The odds of SNHL was higher by 55% in individuals with IDA, compared with individuals without IDA (OR = 1.55, 95% CI 1.17–2.06; P = 0.03). The age-specific ORs were 1.36 (95% CI 1.15–1.61; P = 0.27) and 3.67 (95% CI 1.72–7.84) for adults and children, respectively. IDA may be a contributing factor to hearing loss. Further studies are warranted, including whether IDA treatment reduces the risk of hearing loss. Meanwhile, hearing loss screening in anemic individuals, or vice versa, may represent an important consideration.

PROSPERO registration CRD42017082108


Anemia remains among the major global public health problems, affecting almost a third of the world population (over 2.2 billion people) [1, 2]. Though it is a multifactorial problem, iron deficiency anemia (IDA) is estimated to account for almost half of the global anemia burden. There is a wide variation in the distribution of IDA, with the highest prevalence being in central Asia (64.7%) and lowest in North America (2.9%) [3,4,5]. Hearing loss is also a significant public health challenge of a high, but less recognized, magnitude [6]. Although the figures may vary with the hearing assessment methods and thresholds used, hearing loss was estimated to affect 360 [7] to 554 [8] million individuals globally. Hearing loss is an important contributor to childhood disability [9]. Hearing loss is of negative consequences, including poor psychosocial, cognitive and language developments in children [10] and cognitive decline, dementia, and social isolation in the elderly [11,12,13,14].

Existing evidence showed IDA linked to hearing loss. A higher prevalence of hearing loss was reported in individuals with IDA [15, 16]. The exact mechanism of IDA leading to hearing loss is mainly unclear. Whether IDA treatment improves hearing function is also unclear. However, it has been widely hypothesized to be related to the sensitivity of the cochlea to vascular and neurologic effects of IDA. Cochlea is supplied only by the labyrinthine artery. The lack of collateral circulation could make it more vulnerable to the ischemic effect of IDA [15,16,17,18,19]. To the best of our knowledge, there is no systematic review and meta-analysis report on the association of anemia and hearing impairment. We, therefore, conducted this systematic review and meta-analysis on the link of IDA to sensorineural hearing loss (SNHL).

Main text


This systematic review and meta-analysis was conducted following the recommendations of Meta-analysis of Observational Studies in Epidemiology guideline [20], and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [21]. The work was registered in PROSPERO.

Search strategy and data sources

We searched PubMed, MEDLINE, Embase, Scopus, and Google Scholar for studies published in English from inception to June 30, 2018. We used a combination of search terms including ‘anemia’, ‘anaemia’, ‘iron deficiency anaemia’, ‘iron deficiency anemia’, ‘iron-deficiency anaemia’, ‘iron deficiency anemia’, ‘hearing loss’, ‘deafness’, ‘hearing impairment’, and ‘hearing dysfunction’.

Eligibility criteria

The inclusion criteria were (1) hearing loss measured and reported, (2) IDA measured and reported, and (3) adjusted OR, incidence rate (IR), or relative risk (RR) reported on the association of anemia and hearing loss. The exclusion criteria were any one of the following conditions: (1) animal studies; (2) celiac disease; (3) anemia of causes specified other than iron deficiency; or (4) qualitative studies, commentaries, editorials, and case reports.

Study screening and data extraction

Literature search, title, abstract and full-text screening and reviewing were done by SHM and SA, working independently and in duplicate. The screening and selection processes are illustrated using the PRISMA flow diagram (Additional file 1). From each study, we extracted the following information: (1) study identification (title, first author, year of publication), (2) study characteristics (country, study design, sample size, follow-up period for longitudinal studies), (3) participants’ demographic factors (mean age, proportion of men), (4) IDA assessment method, (5) hearing loss assessment method, (6) measure of anemia and hearing loss association, and (7) variables used for adjustments. The pre-specified measures of association were adjusted OR, RR, or IR of hearing loss in individuals with IDA, compared with those without IDA. When a study reported more than one OR/RR, we took the maximum adjusted one that was adjusted for more variables. Besides, we treated RR as the equivalent of OR. For studies in which the reference of comparison was the risky group (individuals with IDA), we took the inverse of the reported estimate to ensure all estimates use the same reference group (individuals without IDA).

Quality assessment

We assessed the methodological quality of included studies using the Newcastle–Ottawa Scale (NOS) [22]. The grading was out of 9 and a score 0 to 3 was considered low quality, 4 to 6 medium quality, and 7–9 high quality. Ratings for each study were compared between the two evaluators, SHM and SA, with discrepancy resolved by consensus.

Statistical analysis

The OR was used to summarise the estimates, representing the odds of hearing loss in those with IDA, compared with those without IDA. The summary OR was calculated with the DerSimonian and Laird random effect model, which accounts for both within study and between studies variations [23]. Heterogeneity between studies was assessed using the I2-statistics, which quantifies the proportion of variance explained by between-study heterogeneity. According to Higgins et al. [24], I2 < 25%, 25–49%, 50–75%, and > 75% represents no, low, moderate and high levels of heterogeneity, respectively. Potential sources of heterogeneity were identified using subgroup analyses. We intended to assess publication bias using the funnel plot technique, Begg’s rank test, and Egger’s regression test, as appropriate. However, it was not possible as there were inadequate numbers of studies, which under-power any of these methods. A minimum of 10 studies is recommended to evaluate publication bias, although a meta-analysis of 2 or more studies is possible [25]. Stata 15.0 was used for all analyses.


We included a total of four studies [15,16,17,18] in this work. The literature search, selection and reviewing process is shown in the PRISMA flow diagram (Additional file 1). The general characteristic of the studies is presented in Table 1. The studies were published from 2011 to 2017. Of the four studies included in this work, three were cohort and one was case–control. Except one study done in Taiwan, the remaining three studies were conducted in the USA. The quality of the studies was high, all scoring > 7/9 on the NOS quality assessment tool. The sample size of the studies ranged from 2612 to 305,339 individuals. Altogether, the four studies included 344,080 unique individuals, of whom 49.60% were males (n = 151,461) and 50.40% females (n = 153,878). The mean age of participants was 48.2 years. Of the four studies, three were done on adults and one on children and adolescents.

Table 1 Main characteristics of studies included in this meta-analysis

Figure 1 shows the summary estimate of the association of IDA with hearing loss, calculated combining all the studies with random effect model. The estimates (ORs) refer to the odds of hearing impairment among anemic cases, as compared with non-anemic ones. It showed IDA significantly associated with hearing loss (pooled OR = 1.55, 95%CI 1.17-2.06) with a moderate level of heterogeneity (Q = 9.06, df = 3; I2 = 66.9%, P = 0.03 for heterogeneity). Subgroup analysis was conducted by age groups, separating studies on adult and children. Figure 2 shows the results of the subgroup analyses. The child study seemed to explain the heterogeneity between the studies. Exclusion of this study resulted in a lower level of heterogeneity (Adult: Q = 2.63, df = 2; I2 = 23.9%, P = 0.27), but the associations remained significant and almost the same (pooled OR = 1.55, 95 CI% = 1.17–2.06 versus 1.36, 95% CI 1.15–1.61; with and without the child study included). Thus, the summary estimate of odds of SNHL associated with IDA was 1.36 (95% CI 1.15–1.61; I2 = 23.9, P = 0.27) in adults and 3.67 (95% CI 1.72–7.84) in children and adolescents.

Fig. 1

Association of iron deficiency anemia and sensorineural hearing loss

Fig. 2

Subgroup analysis of association iron deficiency anemia and sensorineural hearing loss


We found a significant association between IDA and SNHL among both adults and children. The odds of SNHL was 55% higher in individuals with IDA, compared with those without IDA. A recent study in the USA showed that the prevalence of hearing impairment was 3.0% in children with IDA, but 1.7% in those without IDA [15]. In general, hearing impairment was estimated to affect 10% of the world population in the year 2015 [2], with significant variations across age groups as well as geographic regions. In 2011, 20.6% American adults aged 48–59 years and 90% of those older than 80 years were reported to have hearing impairment [16], with an estimated overall adult prevalence of 14.1% [17].

The mechanism linking IDA and SNHL is uncertain and non-conclusive, through some plausible mechanisms were proposed. A more frequently mentioned mechanism is the vascular hypothesis that the cochlea is susceptible to ischemia due to lack of collateral circulation. Provided iron is essential for the production of hemoglobin, one could presume IDA will likely compromise tissue oxygen delivery [3, 4, 18] and increase the risk of ischemia [18, 26]. Cochlea receives blood from only the labyrinthine artery and would be more vulnerable to a reduction in blood oxygen due to IDA. Another proposed mechanism is the role of iron in the nervous system. Iron is a cofactor in neurotransmitter metabolism, DNA synthesis, and nerve myelination [27, 28]. Neurological disorders like epilepsy, peripheral neuropathy, myoclonus, posterior column demyelination, headache, cerebellar ataxia, brain atrophy, and dementia might be linked to SNHL. Celiac disease has also been associated with hearing impairment, due to reasons including impairment in nutritional status, diarrhea, abdominal distension and weight loss [29].

Anemia and hearing loss are among the top leading contributors to health impairment globally [2]. Anemia prevention and control is a global priority agenda [5]. Unlike anemia, hearing loss is in the rank of neglected problems, with low public health attention [6, 7]. Studies on IDA and hearing loss are limited in number as well as geographic coverage. The existing estimates are based mainly on studies conducted in western countries, where prevalence IDA is low and the possibility of early diagnosis and treatment is better, compared with the regions of Asia and Africa where both IDA and hearing loss burdens are high [8]. Thus, presuming IDA might be a risk factor for hearing loss, we believe that the number of people with hearing loss may be even higher than the reported figures in the literature. Further studies from developing countries would contribute to further understanding the nature and extent of the association of the two conditions.

While IDA remains a major public health problem globally, its association with hearing loss would be more concerning. The existing evidence is limited on whether anemia prevention and treatment reduces the risk of hearing loss or treatment of anemia in individuals with concurrent anemia and hearing impairment improves hearing function. Although the design of the studies included in our work precluded making a causal inference and definitive conclusion, we suggest further studies on the feasibility and effectiveness of hearing loss screening for individuals with anemia or anemia screening for individuals with hearing loss. Prevention, early diagnosis, and treatment of IDA could have dual benefits, reducing the burden of anemia and probably hearing loss. Previous reports also recommended the importance of screening [15, 17, 18]. Consideration of hearing loss screening for anemic individuals may stand more important in settings with high anemia prevalence. Strategies for integrating hearing loss screening for anemic cases, or vice versa, into existing public health and clinical practices need to be explored by further studies. Anemia prevention and control is a centrality in national and global nutrition programs, with established delivery platforms. Thus, integrating hearing loss with anemia prevention and control delivery platforms may be an efficient option, albeit it should be confirmed in future studies.


This study showed a significant association between IDA and hearing loss. The exact mechanism by which IDA contributes to hearing loss, and whether IDA treatment reduces the risk of hearing loss is unclear. Further studies are warranted to better understand the link between IDA and hearing loss and draw public health attention. Besides, the potential of integrating hearing loss screening for anemic patients, or vice versa, needs to be further explored.


  • We found only four studies, which underpowered any of the existing publication bias evaluation methods.

  • Except one study done from Taiwan, the other studies refer only to the US population, limiting the generalizability of the findings to the rest of the world.

  • All studies were observational in design, precluding making causal inferences.

Availability of data and materials

The study is based on extracting data from published articles and all data are included in the report.



confidence interval


iron deficiency anemia


odds ratio


relative risk


sensorineural hearing loss


World Health Organization


  1. 1.

    Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615–24.

    CAS  Article  Google Scholar 

  2. 2.

    Vos T, Allen C, Arora M, Barber RM, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, Coggeshall M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.

    Article  Google Scholar 

  3. 3.

    Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet (London, England). 2016;387(10021):907–16.

    CAS  Article  Google Scholar 

  4. 4.

    Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–43.

    Article  Google Scholar 

  5. 5.

    Mjhjkh S. World Health Organization. Comprehensive implementation plan on maternal, infant, and young child nutrition, Geneva, Switzerland, 2014. Adv Nutr. 2015;6(1):134–5.

    Article  Google Scholar 

  6. 6.

    Emmett SD, West KP Jr. Nutrition and hearing loss: a neglected cause and global health burden. Am J Clin Nutr. 2015;102(5):987–8.

    CAS  Article  Google Scholar 

  7. 7.

    Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ. 2014;92(5):367–73.

    Article  Google Scholar 

  8. 8.

    Stevens G, Flaxman S, Brunskill E, Mascarenhas M, Mathers CD, Finucane M. Global Burden of Disease Hearing Loss Expert G: global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health. 2013;23(1):146–52.

    Article  Google Scholar 

  9. 9.

    Kassebaum N, Kyu HH, Zoeckler L, Olsen HE, Thomas K, Pinho C, Bhutta ZA, Dandona L, Ferrari A, Ghiwot TT, et al. Child and adolescent health from 1990 to 2015: findings from the global burden of diseases, injuries, and risk factors 2015 study. JAMA Pediatrics. 2017;171(6):573–92.

    Article  Google Scholar 

  10. 10.

    Wake M, Hughes EK, Poulakis Z, Collins C, Rickards FW. Outcomes of children with mild-profound congenital hearing loss at 7 to 8 years: a population study. Ear Hear. 2004;25(1):1–8.

    Article  Google Scholar 

  11. 11.

    Deal JA, Sharrett AR, Albert MS, Coresh J, Mosley TH, Knopman D, Wruck LM, Lin FR. Hearing impairment and cognitive decline: a pilot study conducted within the atherosclerosis risk in communities neurocognitive study. Am J Epidemiol. 2015;181(9):680–90.

    Article  Google Scholar 

  12. 12.

    Leverton T. Hearing loss is important in dementia. BMJ. 2015;350:h3650.

    Article  Google Scholar 

  13. 13.

    Schmitz J, Pillion JP, LeClerq SC, Khatry SK, Wu LS, Prasad R, Karna SL, Shrestha SR, West KP Jr. Prevalence of hearing loss and ear morbidity among adolescents and young adults in rural southern Nepal. Int J Audiol. 2010;49(5):388–94.

    Article  Google Scholar 

  14. 14.

    Emmett SD, Francis HW: The socioeconomic impact of hearing loss in U.S. adults. Otol Neurotol 2015, 36(3):545-550.

  15. 15.

    Schieffer KM, Chuang CH, Connor J, Pawelczyk JA, Sekhar DL. Association of iron deficiency anemia with hearing loss in US adults. JAMA Otolaryngol. 2017;143(4):350–4.

    Google Scholar 

  16. 16.

    Chung SD, Chen PY, Lin HC, Hung SH. Sudden sensorineural hearing loss associated with iron-deficiency anemia: a population-based study. JAMA Otolaryngol. 2014;140(5):417–22.

    Google Scholar 

  17. 17.

    Kahlon N, Gandhi A, Mondal S, Narayan S. Effect of iron deficiency anemia on audiovisual reaction time in adolescent girls. Indian J Physiol Pharmacol. 2011;55(1):53–9.

    CAS  PubMed  Google Scholar 

  18. 18.

    Schieffer KM, Connor JR, Pawelczyk JA, Sekhar DL. The relationship between iron deficiency anemia and sensorineural hearing loss in the pediatric and adolescent population. Am J Audiol. 2017;26(2):155–62.

    Article  Google Scholar 

  19. 19.

    Nash SD, Cruickshanks KJ, Klein R, Klein BE, Nieto FJ, Huang GH, Pankow JS, Tweed TS. The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol. 2011;137(5):432–9.

    Article  Google Scholar 

  20. 20.

    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.

    CAS  Article  Google Scholar 

  21. 21.

    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.

    Article  Google Scholar 

  22. 22.

    Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

    Article  Google Scholar 

  23. 23.

    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    CAS  Article  Google Scholar 

  24. 24.

    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

    Article  Google Scholar 

  25. 25.

    Valentine JC, Pigott TD, Rothstein HR. How many studies do you need?: a primer on statistical power for meta-analysis. J Educ Behav Stat. 2010;35(2):215–47.

    Article  Google Scholar 

  26. 26.

    Dubyk MD, Card RT, Whiting SJ, Boyle CA, Zlotkin SH, Paterson PG. Iron deficiency anemia prevalence at first stroke or transient ischemic attack. Can J Neurol Sci. 2012;39(2):189–95.

    Article  Google Scholar 

  27. 27.

    Zhang C. Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control. Protein Cell. 2014;5(10):750–60.

    CAS  Article  Google Scholar 

  28. 28.

    Badaracco ME, Ortiz EH, Soto EF, Connor J, Pasquini JM. Effect of transferrin on hypomyelination induced by iron deficiency. J Neurosci Res. 2008;86(12):2663–73.

    CAS  Article  Google Scholar 

  29. 29.

    Lemajić-Komazec S, Abenavoli L. Iron deficiency anemia and hearing loss. Int J Pediatr Otorhinolaryngol. 2018;113:302.

    Article  Google Scholar 

Download references


None to acknowledge.


This research received no specific grant from any funding agency in public, commercial or not-for-profit sectors.

Author information




SHM conceived and led the study. SHM, SA, and TDH developed search strategies, conducted literature search, screening and review, and extracted data. SHM, SSB, and KD analyzed the data and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shimel Hussien Mohammed.

Ethics declarations

Ethics approval and consent to participate

Not applicable as the study is based on extracting data from published articles.

Consent for publication

Not applicable as the study is based on extracting data from published articles.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file

Additional file 1.

PRISMA flow diagram of study selection and screening.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mohammed, S.H., Shab-Bidar, S., Abuzerr, S. et al. Association of anemia with sensorineural hearing loss: a systematic review and meta-analysis. BMC Res Notes 12, 283 (2019).

Download citation


  • Anemia
  • Hearing loss
  • Hearing impairment
  • Sensorineural hearing loss
  • Review